File SF4250 ("Eliminates drug price increase caps and notice rules") is before the Minnesota Legislature and has not been decided. Latest step (March 9, 2026): Introduction and first reading.
Minnesota file SF4250, before the Minnesota Legislature. Still to be decided as of 2026-03-09.
Prescription drug prices could rise without state limits Minnesotans may face steeper out-of-pocket costs for medications if pharmaceutical companies raise prices beyond current state-imposed caps, which would no longer apply.
Health insurers and public programs absorb higher drug costs State Medicaid, MinnesotaCare, and health insurance plans may see increased expenses for covered drugs, potentially affecting premium rates and program budgets.
Patients lose advance notice of drug market exits Drugmakers would no longer be required to notify the state before discontinuing or withdrawing a medication from the market, potentially creating supply disruptions for patients relying on affected drugs.
Drug price increases restrictions elimination provision and sale or distribution withdraw notice requirement elimination provision
Read the official record for SF4250
See everything up for a vote · This week in Minnesota · See what we have filed with the clerk